...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Free
Message: What about < median LDL-C, and NAFLD question?

NAFLD:  will this be with T2D only?  Any chance that RVX 208 starts to explore outside of T2D.  Correct me if I'm wrong, but aren't there some SGLT2i trials being explored outside of T2D?

 

No mention of below median LDL-C in the letter.  We were very strong in that cohort.

 

Why was there no mention of liver and onions on the menu prior to today?  

Share
New Message
Please login to post a reply